Effect of folic acid supplementation on preterm delivery and small for gestational age births: A systematic review and meta-analysis

Reproductive Toxicology

Volumn 67, Issue , 2017, Pages 35-41

  Zhang, Qian ^a,b,c   Wang, Yuanyuan ^b   Xin, Xiaona ^b,c   Zhang, Ya ^b   Liu, Dujia ^b,c   Peng, Zuoqi ^b   He, Yuan ^b   Xu, Jihong ^b   Ma, Xu ^b,c  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^c GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Folic acid; Preterm delivery; Small for gestational age

Indexed keywords

FOLIC ACID;

ARTICLE; CONCEPTION; HUMAN; MENSTRUAL CYCLE; PREGNANCY OUTCOME; PREMATURE LABOR; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; SMALL FOR DATE INFANT; SUPPLEMENTATION; SYSTEMATIC REVIEW; COHORT ANALYSIS; DIETARY SUPPLEMENT; DRUG ADMINISTRATION; FEMALE; META ANALYSIS; NEWBORN; PREGNANCY; PREMATURITY;

COHORT STUDIES; DIETARY SUPPLEMENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PREGNANCY; PREMATURE BIRTH;

EID: 84996569987     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2016.11.012     Document Type: Article

References (47)

1. [1] Scaglione, F., Panzavolta, G., Folate, folic acid and 5-methyltetrahydrofolate are not the same thing. Xenobiotica 44 (2014), 480–488.
2. [2] Czeizel, A.E., Dudas, I., Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327 (1992), 1832–1835.
3. [3] Czeizel, A.E., Dudas, I., Metneki, J., Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet. 255 (1994), 131–139.
4. [4] Group, M.V.S.R., Prevention of neural tube defects: results of the medical research council vitamin study: MRC vitamin study research group. Lancet 338 (1991), 131–137.
5. [5] Djukic, A., Folate-responsive neurologic diseases. Pediatr. Neurol. 37 (2007), 387–397.
6. [6] Rondo, P.H., Tomkins, A.M., Folate and intrauterine growth retardation. Ann. Trop. Paediatr. 20 (2000), 253–258.
7. [7] Tamura, T., Picciano, M.F., Folate and human reproduction. Am. J. Clin. Nutr. 83 (2006), 993–1016.
8. [8] Scholl, T.O., Johnson, W.G., Folic acid: influence on the outcome of pregnancy. Am. J. Clin. Nutr. 71 (2000), 1295S–1303S.
9. [9] Shaw, G.M., Carmichael, S.L., Nelson, V., Selvin, S., Schaffer, D.M., Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid. Public Health Rep. 119 (2004), 170–173.
10. [10] WHO, Preterm birth. http://www.who.int/mediacentre/factsheets/fs363/en/.
11. [11] Marsal, K., Persson, P.H., Larsen, T., Lilja, H., Selbing, A., Sultan, B., Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 85 (1996), 843–848.
12. [12] Pallotto, E.K., Kilbride, H.W., Perinatal outcome and later implications of intrauterine growth restriction. Clin. Obstet. Gynecol. 49 (2006), 257–269.
13. [13] Steer, P., The epidemiology of preterm labour. BJOG 112:Suppl. 1 (2005), 1–3.
14. [14] Arora, C.P., Kacerovsky, M., Zinner, B., et al. Disparities and relative risk ratio of preterm birth in six Central and Eastern European centers. Croat. Med. J. 56 (2015), 119–127.
15. [15] Stegmann, B.J., Santillan, M., Leader, B., Smith, E., Santillan, D., Changes in antimullerian hormone levels in early pregnancy are associated with preterm birth. Fertil. Steril. 104 (2015), 347–355.
16. [16] Norman, J.E., Shennan, A.H., Prevention of preterm birth–why can't we do any better?. Lancet 381 (2013), 184–185.
17. [17] Lockwood, C.J., Predicting premature delivery–no easy task. N. Engl. J. Med. 346 (2002), 282–284.
18. [18] Yu, S.M., Keppel, K.G., Singh, G.K., Kessel, W., Preconceptional and prenatal multivitamin-mineral supplement use in the 1988 National Maternal and Infant Health Survey. Am. J. Public Health 86 (1996), 240–242.
19. [19] Straus, S.E., Evidence-Based Medicine: How to Practice and Teach It, 4e (Straus, Evidence-Based Medicine). 4th ed., 2010, Churchill Livingstone.
20. [20] Lo, C.K., Mertz, D., Loeb, M., Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med. Res. Methodol., 14, 2014, 45.
21. [21] Catov, J.M., Bodnar, L.M., Olsen, J., Olsen, S., Nohr, E.A., Periconceptional multivitamin use and risk of preterm or small-for-gestational-age births in the Danish National Birth Cohort. Am. J. Clin. Nutr. 94 (2011), 906–912.
22. [22] Czeizel, A.E., Puho, E.H., Langmar, Z., Acs, N., Banhidy, F., Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study. Eur. J. Obstet. Gynecol. Reprod. Biol. 148 (2010), 135–140.
23. [23] Hodgetts, V.A., Morris, R.K., Francis, A., Gardosi, J., Ismail, K.M., Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. BJOG 122 (2015), 478–490.
24. [24] Nilsen, R.M., Vollset, S.E., Monsen, A.L., et al. Infant birth size is not associated with maternal intake and status of folate during the second trimester in Norwegian pregnant women. J. Nutr. 140 (2010), 572–579.
25. [25] Papadopoulou, E., Stratakis, N., Roumeliotaki, T., et al. The effect of high doses of folic acid and iron supplementation in early-to-mid pregnancy on prematurity and fetal growth retardation: the mother-child cohort study in Crete, Greece (Rhea study). Eur. J. Nutr. 52 (2013), 327–336.
26. [26] Pastor-Valero, M., Navarrete-Munoz, E.M., Rebagliato, M., et al. Periconceptional folic acid supplementation and anthropometric measures at birth in a cohort of pregnant women in Valencia, Spain. Br. J. Nutr. 105 (2011), 1352–1360.
27. [27] Bukowski, R., Malone, F.D., Porter, F.T., et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med., 6, 2009, e1000061.
28. [28] Catov, J.M., Bodnar, L.M., Ness, R.B., Markovic, N., Roberts, J.M., Association of periconceptional multivitamin use and risk of preterm or small-for-gestational-age births. Am. J. Epidemiol. 166 (2007), 296–303.
29. [29] Scholl, T.O., Hediger, M.L., Bendich, A., Schall, J.I., Smith, W.K., Krueger, P.M., Use of multivitamin/mineral prenatal supplements: influence on the outcome of pregnancy. Am. J. Epidemiol. 146 (1997), 134–141.
30. [30] Shaw, G.M., Carmichael, S.L., Yang, W., Siega-Riz, A.M., Periconceptional intake of folic acid and food folate and risks of preterm delivery. Am. J. Perinatol. 28 (2011), 747–752.
31. [31] Li, Z., Ye, R., Zhang, L., Li, H., Liu, J., Ren, A., Periconceptional folic acid supplementation and the risk of preterm births in China: a large prospective cohort study. Int. J. Epidemiol. 43 (2014), 1132–1139.
32. [32] Yan, S., Xu, Q., Su, P., Cao, H., Pan, J., Tao, B., Relationship between folic acid supplements during peri-conceptional period and the adverse pregnancy outcomes: a cohort study. Chin. J. Epidemiol. 34 (2013), 1–4.
33. [33] McPartlin, J., Halligan, A., Scott, J.M., Darling, M., Weir, D.G., Accelerated folate breakdown in pregnancy. Lancet 341 (1993), 148–149.
34. [34] Cikot, R.J., Steegers-Theunissen, R.P., Thomas, C.M., de Boo, T.M., Merkus, H.M., Steegers, E.A., Longitudinal vitamin and homocysteine levels in normal pregnancy. Br. J. Nutr. 85 (2001), 49–58.
35. [35] van der Molen, E.F., Verbruggen, B., Novakova, I., Eskes, T.K., Monnens, L.A., Blom, H.J., Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. BJOG 107 (2000), 785–791.
36. [36] Ferguson, S.E., Smith, G.N., Walker, M.C., Maternal plasma homocysteine levels in women with preterm premature rupture of membranes. Med. Hypotheses 56 (2001), 85–90.
37. [37] Lassi, Z.S., Salam, R.A., Haider, B.A., Bhutta, Z.A., Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst. Rev., 3, 2013, D6896.
38. [38] Charles, D.H., Ness, A.R., Campbell, D., Smith, G.D., Whitley, E., Hall, M.H., Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review. Paediatr. Perinat. Epidemiol. 19 (2005), 112–124.
39. [39] Blot, I., Papiernik, E., Kaltwasser, J.P., Werner, E., Tchernia, G., Influence of routine administration of folic acid and iron during pregnancy. Gynecol. Obstet. Invest. 12 (1981), 294–304.
40. [40] Fleming, A.F., Hendrickse, J.P., Allan, N.C., The prevention of megaloblastic anaemia in pregnancy in Nigeria. J. Obstet. Gynaecol. Br. Commonw. 75 (1968), 425–432.
41. [41] Martinussen, M.P., Risnes, K.R., Jacobsen, G.W., Bracken, M.B., Folic acid supplementation in early pregnancy and asthma in children aged 6 years. Am. J. Obstet. Gynecol. 206 (2012), 71–72.
42. [42] Hoag, S.W., Ramachandruni, H., Shangraw, R.F., Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution. J. Am. Pharm. Assoc. (Wash) NS37 (1997), 397–400.
43. [43] CDC, Folic Acid & Birth Defects. http://www.cdc.gov/features/folicacidbenefits/index.html.
44. [44] Reynolds, E., Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 5 (2006), 949–960.
45. [45] Cole, B.F., Baron, J.A., Sandler, R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297 (2007), 2351–2359.
46. [46] Figueiredo, J.C., Grau, M.V., Haile, R.W., et al. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J. Natl. Cancer Inst. 101 (2009), 432–435.
47. [47] Troen, A.M., Mitchell, B., Sorensen, B., et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J. Nutr. 136 (2006), 189–194.